P. Chiodera et al., INFLUENCE OF RESIDUAL C-PEPTIDE SECRETION ON THE ARGININE-VASOPRESSINRESPONSE TO HYPOGLYCEMIA AND METOCLOPRAMIDE IN INSULIN-DEPENDENT DIABETES, European journal of clinical investigation, 25(8), 1995, pp. 568-573
Citations number
34
Categorie Soggetti
Medicine, Research & Experimental","Medicine, General & Internal
Arginine vasopressin (AVP) hypersecretion in response to metoclopramid
e or to insulin-induced hypoglycaemia has been described in type I dia
betes mellitus. In the present study, we examined whether residual end
ogenous insulin secretion may play a role in the control of this abnor
mal AVP secretory pattern. For this purpose, 21 insulin-dependent diab
etic men and 10 age- and weight-matched normal men were tested with MC
P (20mg in an i.v. bolus). On a different occasion, subjects were test
ed with insulin (0.15 IU kg(-1)). The diabetic patients were subdivide
d into C-peptide negative patients (CpN, 11 patients without detectabl
e endogenous pancreatic beta cell activity) (group I) and C-peptide po
sitive patients (CpP, 10 patients with residual endogenous insulin sec
retion) (group II). Experiments started after optimization of the meta
bolic status of the diabetic men by 3 days of treatment with continuou
s subcutaneous insulin infusion. The basal concentrations of AVP were
similar in all groups. The administration of MCP induced a striking el
evation in plasma AVP levels in the normal controls and in the diabeti
c subjects of groups I and II. However, the AVP rise was significantly
higher in group I and group II than in normal controls. Furthermore,
group I diabetics showed higher AVP increments than group II. Insulin
induced a similar hypoglycaemic nadir in all subjects at 30 min, even
though the diabetic subjects of groups I and II had a delayed recovery
in blood glucose levels. The hypoglycaemic pattern was similar in gro
up I and II. Hypoglycaemia induced a striking AVP increase in the norm
al controls. However, significantly higher AVP responses to hypoglycae
mia were observed in the diabetic men of group I and group II than in
the normal controls. Furthermore, group I diabetics showed higher AVP
increments than group II. These data indicate that the hypothalamic-pi
tuitary disorder affecting the AVP response to MCP and insulin-induced
hypoglycaemia in well controlled type I diabetic men is inversely rel
ated to residual p-cen activity.